Universal Biosensors Inc.

ASX:UBI ISIN:AU000000UBI2

 Universal Biosensors (ASX:UBI) is a medical diagnostics company focused on the research, development and manufacture of diagnostic test systems for point-of-care professional and home use. 
 
      

Voir en d'autres langues

Nouvelles

Universal Biosensors (ASX:UBI) annonce le lancement en France du set OneTouch Verio par LifeScan

🕔2/3/2011 10:20:18 AM 11486

La compagnie Universal Biosensors (ASX:UBI) a annoncé aujourd’hui que le nouveau produit de la société LifeScan, le set OneTouch Verio, venait d’être rendu disponible à l’achat en France. Le set OneTouch Verio incorpore la technologie développée par Universal Biosensors et s’adresse à un marché en rapide croissance, celui de l’autosurveillance glycémique.

Lire l'article complet
###

67,313 COMPANY PROFILE VIEWS

  • This Page Viewed: (7 derniers jours: 14) (Last 30 Days: 44) (Since Published: 8746) 

Company Data

    Headquarters
  • 1 Corporate Avenue,
    Rowville, Victoria,
    Australia 3178
  • Telephone
  • +61-3-9213-9000 
  • Fax
  • +61-3-9213-9099 
  • Principal Sector
  • Health & Pharm General 
  • Principal Industry
  • Pharmaceutical 

More News Results

  • 2024/11/19: UBI signs NDC as its distribution partner for Xprecia Prime*
  • 2024/11/08: UBI signs Henry Schein as distribution partner for Xprecia*
  • 2024/10/31: Q3 2024 Results Presentation*
  • 2024/10/31: Q3 2024 Results*
  • 2024/10/31: September 2024 Quarterly Activity Report and Appendix 4C*
  • 2024/10/08: Notification regarding unquoted securities - UBI*
  • 2024/08/26: Xprecia Prime deal in India (Revised)*
  • 2024/08/21: Italy Tender Win for Xprecia Prime*
  • 2024/08/07: Universal Biosensors to host investor briefing and Q&A*
  • 2024/08/02: Half Year Results Presentation - 30 June 2024*
*refer to company website